Biotech · Private company
Hope Biosciences Research Foundation
Track this companyFree. Adds Hope Biosciences Research Foundation to your Dealase workspace and tells you when its record changes.
Clinical trials252 recruiting or active
Pipeline programs23From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline23
- 0.9% sodium chloridePhase 2 · Crohn Disease (CD)ClinicalTrials.gov · fetched Nov 12, 2026
- allogeneic Hope Biosciences adipose-derived mesenchymal stem cellsPhase 2 · Juvenile Idiopathic Arthritis (JIA)ClinicalTrials.gov · fetched Nov 12, 2026
- Autologous HB-adMSCsPhase 2 · Relapsing Remitting Multiple Sclerosis (RRMS)ClinicalTrials.gov · fetched Nov 12, 2026
- Biological/Vaccine: Allogeneic HB-adMSCsPhase 2 · Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCPhase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCsPhase 2 · Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCsPhase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCsPhase 2 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCs - Hope Biosciences Adipose Derived Mesenchymal Stem CellsPhase 2 · Crohn Disease (CD)ClinicalTrials.gov · fetched Nov 12, 2026
- HB- adMSCs (Hope Biosciences adipose derived mesenchymal stem cells)Brain InjuryClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCKnee Pain ChronicClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCChronic PainClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCsSystem; Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCsAmyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCsCerebral PalsyClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCsChronic Inflammatory Demyelinating PolyneuropathyClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCsCongenital Muscular Dystrophy Due to Lamin A/C MutationClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCsPolyneuropathiesClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCsPost COVID-19 SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCsPrimary Lateral Sclerosis, Adult, 1ClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCsSpinal Cord InjuriesClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCsStrokeClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCs - Hope Biosciences Adipose Derived Mesenchymal Stem CellsMultiple System AtrophyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- HB-adMSCs for the Treatment of Crohn's DiseasePHASE2 · RECRUITING · started Jul 14, 2026ClinicalTrials.gov NCT07077746 · fetched Nov 12, 2026
- HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic ArthritisPHASE2 · WITHDRAWN · started Jan 1, 2026ClinicalTrials.gov NCT06623240 · fetched Nov 12, 2026
- "HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"PHASE2 · ACTIVE_NOT_RECRUITING · started May 2, 2025ClinicalTrials.gov NCT06800404 · fetched Nov 12, 2026
- Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple SclerosisPHASE2 · COMPLETED · started Nov 24, 2021ClinicalTrials.gov NCT05116540 · fetched Nov 12, 2026
- Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)PHASE2 · COMPLETED · started Jul 16, 2021ClinicalTrials.gov NCT04995081 · fetched Nov 12, 2026
- Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate)PHASE2 · COMPLETED · started Jun 28, 2021ClinicalTrials.gov NCT04928287 · fetched Nov 12, 2026
- Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19PHASE2 · TERMINATED · started Jun 30, 2020ClinicalTrials.gov NCT04362189 · fetched Nov 12, 2026
- A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs Against COVID-19.PHASE2 · COMPLETED · started May 14, 2020ClinicalTrials.gov NCT04348435 · fetched Nov 12, 2026
- A Clinical Trial to Determine the Safety and Efficacy of HB-adMSCs to Provide Protection Against COVID-19PHASE2 · COMPLETED · started Apr 20, 2020ClinicalTrials.gov NCT04349631 · fetched Nov 12, 2026
- A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's DiseasePHASE1_PHASE2 · WITHDRAWN · started Mar 1, 2020ClinicalTrials.gov NCT04228666 · fetched Nov 12, 2026
- Individual Patient Expanded Access IND of HB-adMSCs for Chronic Musculoskeletal Pain.NO_LONGER_AVAILABLEClinicalTrials.gov NCT04711811 · fetched Nov 12, 2026
- Intermediate Size Patient Population Expanded Access IND for the Treatment of Patients With Parkinson's Disease.NO_LONGER_AVAILABLEClinicalTrials.gov NCT04772378 · fetched Nov 12, 2026
- Intermediate Size Expanded Access Protocol for the Treatment of Post-COVID-19 SyndromeNO_LONGER_AVAILABLEClinicalTrials.gov NCT04798066 · fetched Nov 12, 2026
- "Individual Patient Expanded Access IND to Treat Primary Lateral Sclerosis"NO_LONGER_AVAILABLEClinicalTrials.gov NCT04825613 · fetched Nov 12, 2026
- An Expanded Access IND for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)NO_LONGER_AVAILABLEClinicalTrials.gov NCT04825626 · fetched Nov 12, 2026
- Individual Patient Expanded Access IND of Autologous HB-adMSCs for the Treatment of Systemic Lupus Erythematosus (SLE)NO_LONGER_AVAILABLEClinicalTrials.gov NCT04907175 · fetched Nov 12, 2026
- Individual Patient Expanded Access IND for the Treatment of StrokeNO_LONGER_AVAILABLEClinicalTrials.gov NCT04907188 · fetched Nov 12, 2026
- HBCMD01- Expanded Access for the Treatment of Congenital Muscular Dystrophy.NO_LONGER_AVAILABLEClinicalTrials.gov NCT05154851 · fetched Nov 12, 2026
- "An Intermediate Size Patient Population Expanded Access Protocol to Evaluate the Safety and Efficacy of Allogeneic HB-adMSCs (Hope Biosciences - Adipose Derived Mesenchymal Stem Cells) for the Treatment of Multiple System Atrophy."AVAILABLEClinicalTrials.gov NCT07238062 · fetched Nov 12, 2026
- Intermediate Size Patient Population Expanded Access Protocol to Evaluate HB-adMSCs for the Treatment of Patients With Traumatic or Nontraumatic Brain InjuryNO_LONGER_AVAILABLEClinicalTrials.gov NCT07164482 · fetched Nov 12, 2026
- Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for the Treatment of Cerebral PalsyNO_LONGER_AVAILABLEClinicalTrials.gov NCT04029896 · fetched Nov 12, 2026
- Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Spinal Cord InjuryNO_LONGER_AVAILABLEClinicalTrials.gov NCT04064957 · fetched Nov 12, 2026
- Individual Patient Expanded Access IND to Treat PolyneuropathyNO_LONGER_AVAILABLEClinicalTrials.gov NCT04064983 · fetched Nov 12, 2026
- Individual Patient Expanded Access IND of Autologous HBadMSCs for the Treatment of Amyotrophic Lateral SclerosisNO_LONGER_AVAILABLEClinicalTrials.gov NCT04514952 · fetched Nov 12, 2026
- Individual Patient Expanded Access IND of Autologous HB-adMSCS for the Treatment of Bilateral Knee Pain.NO_LONGER_AVAILABLEClinicalTrials.gov NCT04604288 · fetched Nov 12, 2026